← Back to Search

Behavioral Intervention

Speech Therapy for Speech Sound Disorder (iChain Trial)

N/A
Recruiting
Led By Jonathan Preston, PhD
Research Sponsored by Syracuse University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before the initiation of treatment and again 10 weeks later.
Awards & highlights

iChain Trial Summary

This trial will compare two types of treatment schedules for children with speech sound disorders to see which works better.

Who is the study for?
This trial is for American English-speaking children aged 9 to 17 with speech sound disorders, specifically difficulty with /ɹ/ and /s/ sounds. They must have started learning English by age 3, pass a hearing test, score adequately on language understanding tests, and want to improve their speech. Children with cleft palate, voice disorders, autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability or brain injury are excluded.Check my eligibility
What is being tested?
The study compares two different schedules of Speech Motor Chaining treatment: a 'Distributed' schedule (2 sessions per week for 8 weeks) versus an 'Intensive' schedule (16 hours of treatment over 4 weeks). The aim is to see which schedule better helps school-age children learn correct speech sounds in cases of residual speech sound disorder.See study design
What are the potential side effects?
Since the intervention involves non-medical treatment focused on improving speech through therapy sessions rather than drugs or surgery, there are no direct physical side effects associated with this clinical trial.

iChain Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before the initiation of treatment and again 10 weeks later.
This trial's timeline: 3 weeks for screening, Varies for treatment, and before the initiation of treatment and again 10 weeks later. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in percent correct for treated sound, rated by blinded listeners.
Secondary outcome measures
Proportion of responders and non-responders in each group.
Survey evaluating impacts of speech disorder on participants' social, emotional, and academic well-being.

iChain Trial Design

2Treatment groups
Experimental Treatment
Group I: Intensive TreatmentExperimental Treatment1 Intervention
Speech Motor Chaining will be delivered in an intensive fashion. Week 1: 8 sessions (2 sessions per day on 4 different days) Week 2: 3 sessions (1 per day on 3 different days) Week 3: 3 sessions (1 per day on 3 different days) Week 4: 2 sessions (1 per day on 2 different days)
Group II: Distributed TreatmentExperimental Treatment1 Intervention
Speech Motor Chaining will be delivered twice weekly for 8 weeks

Find a Location

Who is running the clinical trial?

State University of New York - Upstate Medical UniversityOTHER
173 Previous Clinical Trials
27,308 Total Patients Enrolled
1 Trials studying Speech Sound Disorder
26 Patients Enrolled for Speech Sound Disorder
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
330 Previous Clinical Trials
178,387 Total Patients Enrolled
10 Trials studying Speech Sound Disorder
368 Patients Enrolled for Speech Sound Disorder
Syracuse UniversityLead Sponsor
48 Previous Clinical Trials
117,490 Total Patients Enrolled
6 Trials studying Speech Sound Disorder
200 Patients Enrolled for Speech Sound Disorder

Media Library

Intensive Speech Motor Chaining Treatment (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05929859 — N/A
Speech Sound Disorder Research Study Groups: Intensive Treatment, Distributed Treatment
Speech Sound Disorder Clinical Trial 2023: Intensive Speech Motor Chaining Treatment Highlights & Side Effects. Trial Name: NCT05929859 — N/A
Intensive Speech Motor Chaining Treatment (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05929859 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this particular research endeavor accept individuals over thirty-five years of age?

"This research project is open to any participants between 9 and 17 years of age."

Answered by AI

Is there a possibility to participate in this research endeavor?

"In order to take part, participants must be diagnosed with speech sound disorder and aged between 9 and 17 years old. This clinical trial is hoping to enrol 84 individuals in total."

Answered by AI

Is admission to this medical study still available for potential participants?

"Clinicaltrials.gov's records disclose that this clinical trial, which launched on October 1st 2023 and was most recently amended on June 20th of the same year, is not currently recruiting patients. Nonetheless, there are 11 other active medical trials searching for participants at present."

Answered by AI
~56 spots leftby Nov 2027